Similar articles

• A role for glucagon in cardiac therapy.

  Parmley WW, Sonnenblick EH. Parmley WW, et al. Am J Med Sci. 1969 Oct;258(4):224-9. Am J Med Sci. 1969. PMID: 4309903 No abstract available.
• [Effects of glucagon on systemic circulation, coronary blood flow and myocardial oxygen consumption in the anesthetized dog (author's transl)].

  Tarnow J, Gethmann JW, Patschke D, Weymar A, Eberlein HJ. Tarnow J, et al. Arzneimittelforschung. 1975;25(12):1906-10. Arzneimittelforschung. 1975. PMID: 1243661 German.
• Cardiovascular effects of glucagon in man.

  Parmley WW, Glick G, Sonnenblick EH. Parmley WW, et al. N Engl J Med. 1968 Jul 4;279(1):12-7. doi: 10.1056/NEJM196807042790103. N Engl J Med. 1968. PMID: 4872564 Clinical Trial. No abstract available.
• Proceedings: Review of the cardiovascular pharmacology of perhexiline.

  Hudak WJ, Lewis RE, Lucas RW, Kuhn WL. Hudak WJ, et al. Postgrad Med J. 1973 Apr;49:Suppl 3:16-25. Postgrad Med J. 1973. PMID: 4202743 Review. No abstract available.
• Cardiovascular function and halothane.

  Goldberg AH. Goldberg AH. Clin Anesth. 1968;1:23-60. Clin Anesth. 1968. PMID: 4877407 Review. No abstract available.